| ZFN | Zinc-finger Nucleases |
| TALEN | Transcription Activator-like Effector Nucleases |
| CRISPR | Clustered Regularly Interspaced Short Palindrome Repeats |
| hiPSCs | Human induced Pluripotent Stem Cells |
| hPSCs | Human Pluripotent stem cells |
| hESCs | Human Embryonic Stem Cells |
| HIV-1 | Human Immunodeficiency Virus |
| tracrRNA | trans-activating crRNA |
| sgRNA | single-guide RNA |
| IV | Intravenous |
| saCas9 | Staphylococcus aureus Cas9 |
| MPS II | Mucopolysaccharidosis II |
| IDS | Iduronate 2-Sulfatase |
| CNS | Central Nervous System |
| HPV | Human Papillomavirus |
| HTI | Hereditary Tyrosinemia Type I |
| AMD | Age-related Macular Degeneration |
| DMD | Duchenne Muscular Dystrophy |
| ALS | Amyotrophic Lateral Sclerosis |
| OTC | Ornithine Transcarbamylase |
| AAT | Alpha-1 antitrypsin |
| LCA | Leber’s congenital amaurosis |
| HR | Homologous Recombination |
| DTA | Diphtheria A |
| CCR | Chemokine Co-Receptor |
| ERT | Enzyme Replacement Therapy |
| ART | Anti-retroviral therapy |
| NSG | NOD/SCID/IL2rγnull |
| SOD1 | Superoxide Dismutase 1 |
| rAAV | Recombinant Adeno-Associated Viruses |
| AAV | Adeno-Associated Viruses |
| BLT | Bone marrow/liver/thymus |
| SMA | Spinal Muscular Atrophy |
| MHC | Major Histocompatibility Complex |
| PLNP | Polyethylene glycol phospholipid-modified cationic lipid nanoparticle |
| CNS | Central nervous system |
| BBB | Blood brain barrier |
| MOI | Multiplicity of infection |
| NPs | Nanoparticles |